Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fluticasone Versus HFA-beclomethasone Dipropionate for Chronic Asthma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452843/0/.
Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452843/0/. Accessed May 1, 2024.
Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452843/0/
Fluticasone Versus HFA-beclomethasone Dipropionate for Chronic Asthma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 May 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452843/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma
ID - 452843
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452843/0/
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -